| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $367,577 ) |
| | 2024 | 2024 | ADEPTHERA LLC | 3353 ALMA ST APT 245 | PALO ALTO | CA | 94306-3514 | SANTA CLARA | USA | R43AG090115 | Regenerative peptide therapy to accelerate pressure ulcer healing | 000 | 1 | NIH | 9/13/2024 | $367,577 |
|
| Issue Date FY: 2023 ( Subtotal = $335,342 ) |
| | 2023 | 2023 | ADEPTHERA LLC | 3353 ALMA ST | PALO ALTO | CA | 94306-3554 | SANTA CLARA | USA | R43DK138554 | A therapy for improving diabetic ulcer healing | 000 | 1 | NIH | 8/30/2023 | $335,342 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2019 | ADEPTHERA LLC | 3353 ALMA ST SUITE245 | PALO ALTO | CA | 94306-3514 | SANTA CLARA | USA | R43HL149499 | Development of a treatment-resistant hypertension (RHTN) depot therapeutics | 000 | 1 | NIH | 7/23/2021 | $0 |
| | 2021 | 2019 | ADEPTHERA LLC | 3353 ALMA ST SUITE245 | PALO ALTO | CA | 94306-3514 | SANTA CLARA | USA | R43NS110117 | Development of a novel anti-migraine therapeutics | 000 | 1 | NIH | 1/27/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | ADEPTHERA LLC | 3353 ALMA ST SUITE245 | PALO ALTO | CA | 94306-3514 | SANTA CLARA | USA | R43NS110117 | Development of a novel anti-migraine therapeutics | 000 | 1 | NIH | 5/15/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $587,062 ) |
| | 2019 | 2019 | ADEPTHERA LLC | 3353 ALMA ST SUITE245 | PALO ALTO | CA | 94306-3514 | SANTA CLARA | USA | R43HL149499 | Development of a treatment-resistant hypertension (RHTN) depot therapeutics | 000 | 1 | NIH | 8/19/2019 | $338,152 |
| | 2019 | 2019 | ADEPTHERA LLC | 3353 ALMA ST SUITE245 | PALO ALTO | CA | 94306-3514 | SANTA CLARA | USA | R43NS110117 | Development of a novel anti-migraine therapeutics | 000 | 1 | NIH | 8/22/2019 | $248,910 |
| | 2019 | 2017 | ADEPTHERA LLC | 3353 ALMA ST SUITE245 | PALO ALTO | CA | 94306-3514 | SANTA CLARA | USA | R43TR001867 | Novel Therapeutics for Endothelial Dysfunction | 000 | 1 | NIH | 1/4/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2017 | ADEPTHERA LLC | 3353 ALMA ST SUITE245 | PALO ALTO | CA | 94306-3514 | SANTA CLARA | USA | R43HL137496 | Novel Nanomedicine for Treatment-resistant Hypertension (RHTN) | 000 | 1 | NIH | 7/2/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $587,366 ) |
| | 2017 | 2017 | ADEPTHERA LLC | 3353 ALMA ST SUITE245 | PALO ALTO | CA | 94306-3514 | SANTA CLARA | USA | R43TR001867 | Novel Therapeutics for Endothelial Dysfunction | 000 | 1 | NIH | 5/29/2017 | $290,425 |
| | 2017 | 2017 | ADEPTHERA LLC | 3353 ALMA ST SUITE245 | PALO ALTO | CA | 94306-3514 | SANTA CLARA | USA | R43HL137496 | Novel Nanomedicine for Treatment-resistant Hypertension (RHTN) | 000 | 1 | NIH | 3/1/2017 | $296,941 |
| | 2017 | 2015 | ADEPTHERA LLC | 3353 ALMA ST SUITE245 | PALO ALTO | CA | 94306-3514 | SANTA CLARA | USA | R43HL127808 | A hormonal therapy for bronchopulmonary dysplasia | 000 | 1 | NIH | 7/28/2017 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $522,975 ) |
| | 2015 | 2015 | ADEPTHERA LLC | 3353 ALMA STREET | PALO ALTO | CA | 94306 | SANTA CLARA | USA | R41HD082698 | A hormonal therapy for preeclampsia | 000 | 1 | NIH | 1/13/2015 | $223,676 |
| | 2015 | 2015 | ADEPTHERA LLC | 3353 ALMA STREET | PALO ALTO | CA | 94306 | SANTA CLARA | USA | R43HL127808 | A hormonal therapy for bronchopulmonary dysplasia | 000 | 1 | NIH | 8/18/2015 | $299,299 |
|
| Issue Date FY: 2014 ( Subtotal = $450,000 ) |
| | 2014 | 2014 | ADEPTHERA LLC | 3353 ALMA STREET | PALO ALTO | CA | 94306 | SANTA CLARA | USA | R43HD078056 | Prevention of Preeclampsia-associated preterm births | 000 | 1 | NIH | 8/4/2014 | $225,000 |
| | 2014 | 2014 | ADEPTHERA LLC | 3353 ALMA STREET | PALO ALTO | CA | 94306 | SANTA CLARA | USA | R41CA183335 | Developing Novel Therapies for Treating Breast-Cancer-Related Lymphedema | 000 | 1 | NIH | 9/18/2014 | $225,000 |
|
|
